Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication
- Procter and Gamble, Cincinnati, OH
To compare the efficacy of Tc-99m HMDP and Tc-99m MDP to define skeletal lesions, 28 adult patients were examined in a double-blind, randomized, crossover study. Each patient was imaged with both agents over a period of 7-14 days. Both quantitative and qualitative evaluations were performed on the resulting images. Both agents detected the same number of skeletal lesions, and the number of lesions detected was the same whether the imaging was performed 2 or 4 hr after injection. Relative uptake of the tracer in the lesion relative to normal bone was also the same for both agents. Lesions were easier to see at 4 hr after injection than at 2 hr, presumably because soft-tissue levels were lower. Retention of tracer in bone compared with soft tissue was greater, and image quality was judged to be better, with Tc-99m HMDP than with Tc-99m MDP.
- OSTI ID:
- 5148385
- Journal Information:
- J. Nucl. Med.; (United States), Vol. 25:2
- Country of Publication:
- United States
- Language:
- English
Similar Records
A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication
/sup 99m/Tc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content
Related Subjects
RADIOPHARMACEUTICALS
COMPARATIVE EVALUATIONS
SKELETON
SCINTISCANNING
TECHNETIUM 99
IMAGES
ISOMERIC NUCLEI
PATIENTS
PHOSPHATES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
COUNTING TECHNIQUES
DIAGNOSTIC TECHNIQUES
DRUGS
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
NUCLEI
ODD-EVEN NUCLEI
ORGANS
OXYGEN COMPOUNDS
PHOSPHORUS COMPOUNDS
RADIOISOTOPE SCANNING
RADIOISOTOPES
TECHNETIUM ISOTOPES
YEARS LIVING RADIOISOTOPES
550601* - Medicine- Unsealed Radionuclides in Diagnostics